Electromed Inc. (ELMD)
NYSE: ELMDHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ELMD stock chart
Technical analysisKey statistics
All statistics- Market cap
- $187.84M
- P/E (TTM)
- 16.65
- Forward P/E
- 37.67
- EPS (TTM)
- $1.38
- Dividend yield
- None
- 52-week range
- 22.67 – 47.40
- Day range
- 22.89 – 23.24
- Volume / Avg
- 80.79K / 83.59K
- Beta
- —
- Shares outstanding
- 8.17M
52-week range
ELMD stock today
Shares of Electromed (ELMD) finished lower on Nov 20 at $22.98, a drop of 1.20% or $0.28 per share, versus the S&P 500's 3.70% decline. At this level, ELMD sits near the bottom of its 52-week range of $22.67 to $47.40: 51.5% below the high, set on Jul 7, 2026 and 1.4% above the low. ELMD is down 21.1% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 11.3%.
Electromed trades at 16.7x its trailing twelve-month earnings per share of $1.38. Its forward P/E of 37.7x is higher than the trailing multiple, which means analysts expect earnings to decline over the next year.
Summary generated from market data by MetaCap's automated system. Methodology
About Electromed
Company profileElectromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company provides SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CEO
- Mr. James L. Cunniff
- Headquarters
- New Prague, MN
- Employees
- 195
- IPO year
- 2011
- Website
- smartvest.com
Financial highlights
Full financialsIn fiscal 2026, Electromed generated $73.8 million in revenue, up 15.3% from fiscal 2025, its 13th consecutive year of revenue growth. Net income was $11.3 million (+49.9% year over year), for a net margin of 15.3% versus a median of 6.6% in the prior 5 years. Gross margin was 78.5% (up from 78.1%) and operating margin 18.8%.
| Fiscal year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Revenue | $73.78M | $64.00M | $54.72M | $48.07M | $41.66M |
| Growth | +15.28% | +16.97% | +13.83% | +15.38% | +16.51% |
| Net income | $11.30M | $7.54M | $5.15M | $3.17M | $2.31M |
| EPS (diluted) | $1.30 | $0.85 | $0.58 | $0.36 | $0.26 |
Analyst forecast
ForecastConsensus (2 analysts)
strong_buy
Avg. price target
$48.50+111.05%
- Strong buy 0
- Buy 2
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 10, 2026
- EPS actual vs est.
- $0.32 vs —
Electromed peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| FOCLEDAP TMS S.A. ADR | 2.61 | -7.45% | $123.25M | vs ELMD |
| VANIVivani Medical Inc. | 1.14 | +4.59% | $102.83M | vs ELMD |
| STXSStereotaxis Inc. | 0.9422 | -6.71% | $95.03M | vs ELMD |
| HSDTSolana Company Class A | 1.49 | -10.24% | $93.70M | vs ELMD |
| NRXSNeuraxis Inc. | 4.22 | -6.22% | $59.90M | vs ELMD |
| HYPRHyperfine Inc. Class A | 0.5465 | +4.27% | $57.96M | vs ELMD |
| CVCapsoVision Inc. | 6.11 | -3.17% | $327.56M | vs ELMD |
| OMOutset Medical Inc. | 2.81 | -3.44% | $53.03M | vs ELMD |
Indexes, lists and sector
Electromed stock FAQ
What is Electromed's stock price today?
ELMD last traded at $22.98 as of Nov 20, 4:00 PM EST, down 1.20% on the day. Prices are delayed at least 15 minutes.
What is ELMD's P/E ratio?
ELMD trades at a trailing P/E ratio of 16.65 and a forward P/E of 37.67.
Who is Electromed's CEO?
Mr. James L. Cunniff is the chief executive officer of Electromed Inc., which has about 195 employees.
What is the ELMD 52-week high?
The 52-week high for ELMD is $47.40 and the 52-week low is $22.67. The stock is currently 51.5% below its high.